|
|
|
Volumn 2, Issue 3, 2001, Pages 415-418
|
|
Donitriptan Pierre Fabre
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALMOTRIPTAN;
ANTIMIGRAINE AGENT;
DIHYDROERGOTAMINE;
DONITRIPTAN;
NARATRIPTAN;
NITRIC OXIDE SYNTHASE;
RIZATRIPTAN;
SEROTONIN;
SEROTONIN 1A RECEPTOR;
SEROTONIN 1B RECEPTOR;
SEROTONIN 1D AGONIST;
SEROTONIN 1D RECEPTOR;
SUMATRIPTAN;
TRYPTAMINE DERIVATIVE;
UNCLASSIFIED DRUG;
ZOLMITRIPTAN;
BREATHING RATE;
CAROTID ARTERY FLOW;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ACTIVITY;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
DRUG SELECTIVITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
EXOPHTHALMOS;
HEADACHE;
HUMAN;
HYPOTHERMIA;
MIGRAINE;
MYDRIASIS;
NONHUMAN;
REACTION ANALYSIS;
RECEPTOR AFFINITY;
RESTLESSNESS;
REVIEW;
SIDE EFFECT;
SMOOTH MUSCLE CONTRACTION;
STRUCTURE ACTIVITY RELATION;
STRUCTURE ANALYSIS;
TACHYCARDIA;
TOXICITY TESTING;
VASCULAR RESISTANCE;
VOCALIZATION;
ANIMALS;
CLINICAL TRIALS, PHASE I;
DRUG EVALUATION, PRECLINICAL;
DRUGS, INVESTIGATIONAL;
HUMANS;
MIGRAINE DISORDERS;
MOLECULAR STRUCTURE;
NITRILES;
PIPERAZINES;
SEROTONIN AGONISTS;
TRYPTAMINES;
|
|
EID: 0035059792
PISSN: 09678298
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (6)
|
|
References (13)
|
